Pure Global

Cardiac Resynchronization therapy -Cardioverter/Defibrillator - India CDSCO Medical Device Registration

Cardiac Resynchronization therapy -Cardioverter/Defibrillator is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2021/000222_96b147b9a6501ec59e177e305240b65a_a8bdc2ebd8050f8c4affcbcc2899e75e. This device is marketed under the brand name Optisure. The license holder is M/s St. Jude Medical India Pvt. Ltd, and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Cardiac Resynchronization therapy -Cardioverter/Defibrillator
UID: IMP/MD/2021/000222_96b147b9a6501ec59e177e305240b65a_a8bdc2ebd8050f8c4affcbcc2899e75e

Brand Name

Optisure

Device Class

Class D

Approving Authority

CDSCO

Product Information

The devices are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. Cardiac Resynchronization Therapy devices (Optisure) are also intended to resynchronize the right and left ventricles in patients with congestive heart failure. AT/AF Detection Algorithm. The AT/AF detection algorithm is indicated for detecting atrial tachyarrhythmias which have been found to be associated with an increased risk of stroke in elderly, hypertensive, pacemaker patients without prior history of AF

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing